6.
Dao M, Habes D, Taupin J, Mussini C, Redon M, Suberbielle C
. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients. Liver Transpl. 2018; 24(7):897-907.
DOI: 10.1002/lt.25187.
View
7.
Slotkin T, Seidler F, Kavlock R, Bartolome J
. Thyroid hormone differentially regulates cellular development in neonatal rat heart and kidney. Teratology. 1992; 45(3):303-12.
DOI: 10.1002/tera.1420450309.
View
8.
Majumder P, Boss J
. CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus. Mol Cell Biol. 2010; 30(17):4211-23.
PMC: 2937552.
DOI: 10.1128/MCB.00327-10.
View
9.
Pamer E, Cresswell P
. Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol. 1998; 16:323-58.
DOI: 10.1146/annurev.immunol.16.1.323.
View
10.
Soyoz M, Pehlivan M, Tatar E, Cerci B, Coven H, Kilicaslan Ayna T
. Consideration of IL-2, IFN-γ and IL-4 expression and methylation levels in CD4+ T cells as a predictor of rejection in kidney transplant. Transpl Immunol. 2021; 68:101414.
DOI: 10.1016/j.trim.2021.101414.
View
11.
Sindhi R, Higgs B, Weeks D, Ashokkumar C, Jaffe R, Kim C
. Genetic variants in major histocompatibility complex-linked genes associate with pediatric liver transplant rejection. Gastroenterology. 2008; 135(3):830-9, 839.e1-10.
PMC: 2956436.
DOI: 10.1053/j.gastro.2008.05.080.
View
12.
Zernich D, Purcell A, Macdonald W, Kjer-Nielsen L, Ely L, Laham N
. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J Exp Med. 2004; 200(1):13-24.
PMC: 2213310.
DOI: 10.1084/jem.20031680.
View
13.
Kobayashi T, Yokoyama I, Hayashi S, Negita M, Namil Y, Katayama A
. TAP1, TAP2, LMP2, DMA, and DMB genetic polymorphisms in renal transplantation. Transplant Proc. 1998; 30(1):29-30.
DOI: 10.1016/s0041-1345(97)01170-6.
View
14.
Burger L, Gaidatzis D, Schubeler D, Stadler M
. Identification of active regulatory regions from DNA methylation data. Nucleic Acids Res. 2013; 41(16):e155.
PMC: 3763559.
DOI: 10.1093/nar/gkt599.
View
15.
Ashokkumar C, Soltys K, Mazariegos G, Bond G, Higgs B, Ningappa M
. Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children. Transplantation. 2016; 101(1):131-140.
PMC: 5011025.
DOI: 10.1097/TP.0000000000001076.
View
16.
Soltys K, Mazariegos G, Squires R, Sindhi R, Anand R
. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant. 2007; 7(9):2165-71.
DOI: 10.1111/j.1600-6143.2007.01893.x.
View
17.
Miyagawa-Hayashino A, Yoshizawa A, Uchida Y, Egawa H, Yurugi K, Masuda S
. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts. Liver Transpl. 2012; 18(11):1333-42.
DOI: 10.1002/lt.23534.
View
18.
Houseman E, Accomando W, Koestler D, Christensen B, Marsit C, Nelson H
. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012; 13:86.
PMC: 3532182.
DOI: 10.1186/1471-2105-13-86.
View
19.
Wozniak L, Hickey M, Venick R, Vargas J, Farmer D, Busuttil R
. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation. 2015; 99(7):1416-22.
PMC: 5283576.
DOI: 10.1097/TP.0000000000000796.
View
20.
Kamei H, Masuda S, Nakamura T, Oike F, Takada Y, Hamajima N
. Association of transporter associated with antigen processing (TAP) gene polymorphisms in donors with acute cellular rejection in living donor liver transplantation. J Gastrointestin Liver Dis. 2013; 22(2):167-71.
View